'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al.

Subjects

Subjects :

Humans
Adalimumab therapeutic use
Antibodies, Monoclonal therapeutic use
Treatment Outcome
Antirheumatic Agents therapeutic use
Arthritis, Psoriatic drug therapy
Psoriasis drug therapy

Details

Language :

English

ISSN :

1468-3083

Volume :

38

Issue :

2

Database :

MEDLINE

Journal :

Journal of the European Academy of Dermatology and Venereology : JEADV

Publication Type :

Editorial & Opinion

Accession number :

37708568

Full Text :

https://doi.org/10.1111/jdv.19517